Uscom Limited (UCM) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is an ASX listed medical technology company specialising in development and marketing of non-invasive cardiovascular and pulmonary medical devices. The Company has three practice suites of devices in the field of cardiac, vascular and pulmonary monitoring; the USCOM 1A advanced haemodynamic monitor, Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers
| ASX Code | UCM |
| Website | http://www.uscom.com.au |
| Industry/Sector | Health Care Equipment |
| Market Cap ($M) | 3 |
| UCM Share Price | $0.012 |
| Day High | $0.012 |
| Day Low | $0.012 |
| Last Close | $0.012 |
| UCM Share Price Movement | - ( No change ) |
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from USCOM Ltd (UCM) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | -$2.96 | -$1.60 | 38.10% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$2.07 | -$1.20 | -20.80% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2023A | -$2.59 | -$1.50 | 29.60% | 0.00 | 0.00 | 0.00% | 0.0% |
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| Cochlear Limited (COH) | $8,901M | -0.3136 | 0.2540 | 0.0785 | 33.1345 | 26.4231 | 24.5000 | 2.53% | 2.63% | 2.87% |
| Fisher & Paykel Healthcare Corporation Limited (FPH) | $21,395M | 0.1388 | 0.1651 | 0.1747 | 55.0885 | 47.2810 | 40.2497 | 1.19% | 1.29% | 1.46% |
| ResMed Inc. (RMD) | $19,361M | 9.5922 | 0.0985 | 0.0885 | 21.2584 | 19.3522 | 17.7780 | 1.09% | 1.19% | 1.28% |
| USCOM Ltd (UCM) | $3M | 0.3814 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | -60.00 | 0.00 |
| Market | 0.37 | 13.40 | 1.17 | 0.80 |
| Sector | 0.63 | 21.10 | 1.80 | 3.03 |
| Name | Position | Start Date |
|---|---|---|
| Mr Robert Allan Phillips | Chief Executive Officer, Executive Chairman, Executive Director | 23 Dec 1999 |
| Mr Brett Thomas Crowley | Company Secretary, Non Executive director | 23 Aug 2018 |
| Mr Xianhui Meng | Non-Executive Director | 16 Dec 2019 |
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 25 Oct 2024 | PHILLIPS, Robert | Issued | Related Securities | 9,670,117 | $0.026 | $250,027.000 |
| 5 Mar 2024 | PHILLIPS, Robert | Issued | Direct Shares | 18,802,525 | $0.037 | $695,693.430 |
| 4 Mar 2024 | PHILLIPS, Robert | Issued | Direct Shares | 13,495,411 | $0.037 | $499,330.000 |
See all changes in directors' interest & trades for USCOM Ltd (UCM) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
| Name | Position |
|---|---|
| Nick Schicht | General Manager |
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in USCOM Ltd (UCM). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 0 (36.12%) | Robert Allan Phillips |
| 0 (21.11%) | HSBC Custody Nominees |
| 0 (12.20%) | Neja Pty Ltd |
| Date | Event |
|---|---|
| 26 February 2027 | Report (Interim) |
| 25 September 2026 | Report (Annual) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.